![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mahindra Anuj Cirstea Diana Raje Noopur
Publisher: Future Medicine
ISSN: 1479-6694
Source: Future Oncology, Vol.6, Iss.3, 2010-03, pp. : 407-418
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Therapeutic Strategy for Multiple Myeloma
Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma
By Harvey R Donald Lonial Sagar
Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)